Recruiting
Phase 2

Lorlatinib

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07415005

Conditions

Advanced Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lorlatinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-18. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-05.